N-Nitrosamine Formation in Pharmaceutical Drug Products: Development and Validation of a Biased, Conservative, Predictive Model
{{output}}
Following the discovery of N-nitrosamines in a range of medicinal products, regulatory agencies have required marketing authorization holders to undertake risk assessments for the presence of N-nitrosamines in their drug products. This work focusses on a solut... ...
